Inflammatory Bowel Disease Clinical Trial
Official title:
Real-time Diagnosis of Pseudopolyps During Colonoscopy Using Noninvasive Advanced Endoscopic Techniques - a Prospective Study
Significance: Biopsy of potentially benign pseudopolyps and the surrounding mucosa adds
expense and prolongs the time of endoscopic procedures. Use of endoscopic technologies could
decrease the need and expense of endoscopic biopsy for these lesions.
Hypothesis: Pseudopolyps will have a distinctive pattern with the specialized imaging
techniques of high definition imaging, narrow band imaging, and endoscopic dye-spraying
techniques using indigo carmine which will predict diagnosis without biopsy.
100 patients with inflammatory bowel disease will be enrolled in the study. Following a
standard bowel preparation, each patient will be evaluated using standard endoscopic
equipment. All patients will receive a standard bowel preparation (sodium phosphate,
PEG-3350, or magnesium citrate based preparations). All colonoscopic evaluations will be
performed for indications unrelated to the present study, including evaluation of response to
medical treatment, routine surveillance exams for dysplasia, diarrhea, or rectal bleeding.
Polypoid lesions will be examined using four consecutive methods: (a) high definition white
light, (b) narrow band imaging, (c) chromoendoscopy (high definition white light with indigo
carmine dye-spraying), and (d) histologic examination following biopsy. The flat mucosa
surrounding the polypoid lesions will also be examined using theses four techniques in an
effort to identify dysplastic tissue associated with these polypoid growths.
High definition white light is the standard imaging modality used for colonoscopy. Narrow
band imaging (blue wavelength of light) is also used routinely and is available on all
current generation colonoscopes with the press of a button. Our division routinely uses
chromoendoscopy as part of surveillance for dysplasia in patients with inflammatory bowel
disease. Dye spraying catheters or flushing will be utilized for dye application to mucosa.
The dye used will be indigo carmine.
Directed biopsy specimens will then be performed using a multibite forceps for targeted
biopsies. Routine biopsies will be performed as clinically indicated. Pathology slides will
be reviewed by the gastrointestinal pathologists at the University of Miami. The
gastroenterologist's interpretation based on each of the three successive endoscopic methods
will then be compared to the histologic evaluation with each individual lesion serving as its
own control.
The colonoscopy with biopsies will be done as standard of care; additional biopsies will be
taken for research purposes as detailed above. All of the imaging techniques are part of the
accepted standard of care as follows: high definition white light, narrow band imaging,
chromoendoscopy, and histologic examination following biopsy. Comparison of the predictive
values of the imaging modalities in predicting histology from biopsy underlies the primary
question of this research protocol. Cost analysis of modalities versus histology will also be
performed. Time for use of the individual modalities will be recorded.
Subjects will be identified by one of the investigators during their outpatient clinic visits
or while inpatient at University of Miami Hospital. Subjects who meet the inclusion/exclusion
criteria and are scheduled to undergo a colonoscopy for standard of care purposes will be
asked to participate in the study. Patients over 18 years of age with a confirmed diagnosis
of inflammatory bowel disease with plans for routine colonoscopic evaluation and able to
provide informed consent will be included.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03278912 -
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
|
||
Terminated |
NCT00061282 -
Clotrimazole Enemas for Pouchitis in Children and Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05579392 -
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
|
N/A | |
Completed |
NCT03264690 -
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
|
||
Recruiting |
NCT02861053 -
Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?
|
N/A | |
Recruiting |
NCT02275676 -
Resting Energy Expenditure and Nutritional Status in IBD
|
N/A | |
Completed |
NCT02161640 -
Vascular Dysfunction in Paediatric IBD
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01852760 -
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
|
N/A | |
Completed |
NCT01860651 -
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT01933867 -
Water-aided Colonoscopy in Inflammatory Bowel Disease Patients
|
N/A | |
Completed |
NCT01688557 -
Trial on Innovative Technologies in Colonoscopy
|
N/A | |
Completed |
NCT01692743 -
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
|
Phase 3 | |
Completed |
NCT01676324 -
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01666535 -
Infliximab IBD Influenza Vaccine Study
|
N/A | |
Completed |
NCT01981616 -
Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
|
Phase 1 | |
Completed |
NCT01221818 -
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT02322008 -
Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice
|
N/A |